beta-Thujene

Details

Top
Internal ID 2bd09fc9-bc38-4c99-b25f-90589360135b
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Monoterpenoids > Bicyclic monoterpenoids
IUPAC Name 4-methyl-1-propan-2-ylbicyclo[3.1.0]hex-2-ene
SMILES (Canonical) CC1C=CC2(C1C2)C(C)C
SMILES (Isomeric) CC1C=CC2(C1C2)C(C)C
InChI InChI=1S/C10H16/c1-7(2)10-5-4-8(3)9(10)6-10/h4-5,7-9H,6H2,1-3H3
InChI Key GJYKUZUTZNTBEC-UHFFFAOYSA-N
Popularity 168 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H16
Molecular Weight 136.23 g/mol
Exact Mass 136.125200510 g/mol
Topological Polar Surface Area (TPSA) 0.00 Ų
XlogP 3.40
Atomic LogP (AlogP) 2.85
H-Bond Acceptor 0
H-Bond Donor 0
Rotatable Bonds 1

Synonyms

Top
2-Thujene
Bicyclo[3.1.0]hex-2-ene, 4-methyl-1-(1-methylethyl)-
28634-89-1
.beta.-Thujene
4-Methyl-1-(1-methylethyl)bicyclo(3.1.0)hex-2-ene
CHEBI:138047
GJYKUZUTZNTBEC-UHFFFAOYSA-N
1-Isopropyl-4-methylbicyclo[3.1.0]hex-2-ene
C21702
4-methyl-1-propan-2-ylbicyclo[3.1.0]hex-2-ene
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of beta-Thujene

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9939 99.39%
Caco-2 + 0.5305 53.05%
Blood Brain Barrier + 1.0000 100.00%
Human oral bioavailability + 0.7571 75.71%
Subcellular localzation Lysosomes 0.7909 79.09%
OATP2B1 inhibitior - 0.8641 86.41%
OATP1B1 inhibitior + 0.9580 95.80%
OATP1B3 inhibitior + 0.9491 94.91%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior - 0.9507 95.07%
P-glycoprotein inhibitior - 0.9695 96.95%
P-glycoprotein substrate - 0.8773 87.73%
CYP3A4 substrate - 0.6123 61.23%
CYP2C9 substrate - 0.7853 78.53%
CYP2D6 substrate - 0.7460 74.60%
CYP3A4 inhibition - 0.7603 76.03%
CYP2C9 inhibition - 0.8873 88.73%
CYP2C19 inhibition - 0.8444 84.44%
CYP2D6 inhibition - 0.9328 93.28%
CYP1A2 inhibition - 0.8100 81.00%
CYP2C8 inhibition - 0.9842 98.42%
CYP inhibitory promiscuity - 0.7627 76.27%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.6036 60.36%
Carcinogenicity (trinary) Non-required 0.4663 46.63%
Eye corrosion + 0.5679 56.79%
Eye irritation + 0.8600 86.00%
Skin irritation + 0.8224 82.24%
Skin corrosion - 0.8736 87.36%
Ames mutagenesis - 0.7300 73.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5951 59.51%
Micronuclear - 0.8900 89.00%
Hepatotoxicity + 0.6250 62.50%
skin sensitisation + 0.8987 89.87%
Respiratory toxicity + 0.5111 51.11%
Reproductive toxicity - 0.5111 51.11%
Mitochondrial toxicity - 0.5825 58.25%
Nephrotoxicity - 0.6856 68.56%
Acute Oral Toxicity (c) III 0.6338 63.38%
Estrogen receptor binding - 0.9532 95.32%
Androgen receptor binding - 0.6634 66.34%
Thyroid receptor binding - 0.8630 86.30%
Glucocorticoid receptor binding - 0.9072 90.72%
Aromatase binding - 0.9032 90.32%
PPAR gamma - 0.8781 87.81%
Honey bee toxicity - 0.6282 62.82%
Biodegradation - 0.5750 57.50%
Crustacea aquatic toxicity + 0.5900 59.00%
Fish aquatic toxicity + 0.9640 96.40%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 96.86% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.12% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.17% 97.09%
CHEMBL221 P23219 Cyclooxygenase-1 86.20% 90.17%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 84.22% 85.14%
CHEMBL268 P43235 Cathepsin K 81.45% 96.85%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 80.91% 91.11%
CHEMBL4481 P35228 Nitric oxide synthase, inducible 80.37% 94.80%

Cross-Links

Top
PubChem 520384
NPASS NPC139557
LOTUS LTS0268450
wikiData Q408209